Sowell Financial Services’s aTyr Pharma ATYR Stock Holding History

Sowell Financial Services’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	–	–	2817
2021 Q1	$0	Buy	+100	New	+$470	﹤0.01%	3323

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Sowell Financial Services's ATYR Position: Q2 2021 in Review

Sowell Financial Services sold out of aTyr Pharma (ATYR) in Q2 2021, closing a stake of 100 shares.

Sowell Financial Services first reported a position in ATYR in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 29 funds tracked by Wall St. Rank hold ATYR as of Q2 2021.

Sowell Financial Services reported no remaining aTyr Pharma position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 100 aTyr Pharma shares in Q2 2021.
Sowell Financial Services first reported a position in aTyr Pharma in Q1 2021 and held it in 1 quarter.
Sowell Financial Services's aTyr Pharma position peaked at $0 in Q1 2021.
29 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.